Prescriva logo

Prescriva Review

7.0
★★★★☆3.5/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10

Best for: people who want compounded semaglutide or tirzepatide with the pharmacy names published up front

Prescriva scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$249per 4 weeks

Tirzepatide

$339per 4 weeks

Price checked on Prescriva's site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Prescriva is a Sacramento telehealth platform that sells compounded semaglutide and tirzepatide, with prescribing by OpenLoop Health clinicians and three named compounding pharmacies. Plans cost $249 for semaglutide injections, $279 for semaglutide tablets and $339 for tirzepatide, charged every 4 weeks rather than monthly.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral OptionFree ShippingHSA/FSA Eligible

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Prescriva

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Prescriva logo
3.5 / 5
Our editorial rating
Visit Prescriva →

from $249/4 wks · no insurance needed

Prescriva at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$249/4 wks (billed per 4 weeks)
What's included
Medication · Consult · Shipping
FDA status
No FDA warning letter on record

How we scored Prescriva

Each dimension is scored algorithmically from Prescriva'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.2/10

Prescriva's headline is $249 every 4 weeks. Compare it with other programs on the same plan basis.

Effectiveness25%

8.2/10

Prescriva offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.4/10

Online intake and platform experience (consult included in the price); 6 platform features disclosed.

Trust & Safety15%

7.3/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.5/10

Prescriva's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.

Support10%

5.9/10

Prescriva provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Prescriva review

Last checked October 2026
  • Confirmed current pricing across 3 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$249–$339 per 4 weeks across 3 dose/plan tiers (checked October 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Prescriva

We walked Prescriva's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Check Eligibility opens a one-question screen asking whether you are enrolled in Medicare
  2. 2One form asks for name, date of birth, sex, height, weight, email, mobile phone, state and ZIP, and shows your BMI
  3. 3Two checkboxes are required to continue: consent to text messages and an auto-renewal acknowledgment
  4. 4About 15 health screens cover goals, medical conditions, past weight-loss medicine, current medications, blood pressure and heart rate
  5. 5After you submit, a plan page lets you pick the medication and a 4, 12, 24 or 48-week supply
  6. 6A secure card checkout shows the amount due today and the 28-day billing cycle (walk stopped here)
Price shown before you start
  • Plan prices are on the website, and the same $249, $279 and $339 figures appear at checkout
  • The checkout reads "Billed every 28 days" and the plan page says "billed every 4 weeks", while the site and intake say monthly
  • Payment is taken at checkout; the consent page says a clinician consults with you after checkout
  • Longer supplies are one upfront charge: $2,327 for 48 weeks of semaglutide injections
  • The microdose intake asks you to agree to get GLP-1 medicine only through this platform, and answering no ends the assessment
  • Text-message consent is required to continue past the first form
  • We did not take the medication; nothing here describes a patient outcome

Prescriva customer support

GLP-1 medications Prescriva offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Month-to-month plan, weekly injection, charged every 4 weeksCompounded
$249per 4 weeks
semaglutide

Charged every 28 days (13 charges a year). 12, 24 and 48-week supplies cost $657, $1,194 and $2,327, each paid upfront

Month-to-month plan, daily dissolving tablet, charged every 4 weeksCompounded
$279per 4 weeks
semaglutide

Charged every 28 days. 12, 24 and 48-week supplies cost $777, $1,434 and $2,717, each paid upfront

Month-to-month plan, weekly injection, charged every 4 weeksCompounded
$339per 4 weeks
tirzepatide

Charged every 28 days (13 charges a year). 12, 24 and 48-week supplies cost $927, $1,734 and $3,497, each paid upfront

Ready to get started?

Plans and promotions change often, so check Prescriva's current pricing and active discounts before you decide.

See Prescriva pricing →

What we like

  • Names its medical group, OpenLoop Health, and all three dispensing pharmacies with addresses in its terms
  • Injection plan prices are listed on the site before you start the assessment
  • The price covers the clinician visit, the medication and free priority shipping, with no separate membership fee
  • Offers semaglutide as a weekly injection or a daily dissolving tablet, plus tirzepatide injections
  • You get a full refund of the current charge if the clinician decides treatment is not right for you
  • You can cancel or pause from your patient dashboard, with no cancellation fee
  • Publishes a support phone number, and HSA or FSA cards are accepted

Watch-outs

  • Plans are charged every 4 weeks, so a year brings 13 charges rather than 12, though the site says per month
  • The $194 semaglutide figure is a 48-week supply paid upfront at $2,327 and divided by 12, not a monthly price
  • The pricing page also shows a $109 starting price and a $289 semaglutide price that match no plan in checkout
  • You pay at checkout before a clinician reviews your answers
  • Refunds stop once a clinician consultation is completed or medication ships, and partial cycles are not refunded
  • The intake requires you to agree to text messages before you can continue
  • The intake shows an "Excellent 4.9" rating with no source, while the company's review profile has no reviews yet
  • The terms say service is offered in all 50 states, but the FAQ says most states

Is Prescriva worth it?

Prescriva is built for people who want compounded semaglutide or tirzepatide with the pharmacy names published up front. It runs $249 every 4 weeks. The cost section below explains how that price is billed and what it covers, so you can line it up against other programs on the same basis. Its standout is a needle-free oral option for people who would rather not inject.

Beyond the medication itself, Prescriva takes HSA/FSA payment.

How much Prescriva costs

Compounded semaglutide runs $249–$279 every 4 weeks depending on plan; the low end is $249 every 4 weeks and compounded tirzepatide runs $339 every 4 weeks.

Prescriva's headline figure is $249 every 4 weeks, which is how the price is listed on its own site. When you compare it with the alternatives below, line them up on the same billing basis and check what each plan includes.

RxSpan MD (about $249/month) is one of the closest alternatives to weigh Prescriva against.

Medications: what Prescriva prescribes

Prescriva prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.

Prescriva's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: compounded oral, sublingual and buccal versions of these peptides are far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Prescriva is best for, and who should skip it

A good fit if you…

  • are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
  • want the medication and clinician care, plus shipping, covered by one price instead of billed separately.
  • want both semaglutide and tirzepatide on the menu, so you can change molecules without changing providers.
  • plan to pay with an HSA or FSA card.

Look elsewhere if you…

  • specifically want FDA-approved brand-name medication instead of a compounded formulation, since this provider lists no brand-name price.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Prescriva is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see Prescriva against the wider field, use our ranking of semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.

The Bottom Line

Prescriva scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7/10Best for: people who want compounded semaglutide or tirzepatide with the pharmacy names published up frontFrom: $249 every 4 weeks

Ready to start with Prescriva?

From $249 every 4 weeks. See current pricing and start your online intake.

Prescriva might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Prescriva vs…

Prescriva scores7.0/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Prescriva is a Sacramento telehealth platform that sells compounded semaglutide and tirzepatide, with prescribing by OpenLoop Health clinicians and three named compounding pharmacies. Plans cost $249 for semaglutide injections, $279 for semaglutide tablets and $339 for tirzepatide, charged every 4 weeks rather than monthly. We scored it 7.0/10 across our six-dimension editorial framework.
Prescriva is an operating telehealth provider, and we found no FDA warning letter on file for it. Its public pages don't show a LegitScript certification or the name of the pharmacy that fills its prescriptions. We last checked its prices and policies on its own site in October 2026. We scored it 7.0/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
Prescriva starts at $249 every 4 weeks. See the pricing table above for every tier.
Prescriva doesn't use public promo or coupon codes. Third-party sites advertising "Prescriva discount codes" are typically fake; any current offer applies automatically through the link on this page.
Prescriva hasn't published its exact state footprint. Confirm coverage in your state before signing up.
Prescriva offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). These are dispensed as compounded formulations. A needle-free oral option is also available.
Prescriva dispenses compounded GLP-1s made by a licensed compounding pharmacy, with the same active ingredient as the brand drugs at a lower cash price. Compounded drugs are not FDA-approved as finished products; we cover what that means in the review.
Prescriva is a cash-pay program (no insurance required) and accepts FSA/HSA cards.
Prescriva's price includes medication, the clinician consult and shipping. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician looks at whether a GLP-1 fits your situation, and, if you're approved, your medication ships to your door. You can begin the consultation directly on Prescriva's site.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Prescriva. The concerns our review flags: Plans are charged every 4 weeks, so a year brings 13 charges rather than 12, though the site says per month; the $194 semaglutide figure is a 48-week supply paid upfront at $2,327 and divided by 12, not a monthly price; the pricing page also shows a $109 starting price and a $289 semaglutide price that match no plan in checkout; you pay at checkout before a clinician reviews your answers. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Prescriva review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Prescriva's current pricing

Plans from $249 every 4 weeks. Start the online intake to check eligibility and today's price.